Comprehensive Biochemistry Study Notes: Amino Acids, Protein Dynamics, Digestive Pathways, Nitrogen Catabolism, Nucleotide Metabolism, and Oxidative Phosphorylation

Fundamental Building Blocks: Amino Acids and the Peptide Bond

  • General Structure of α\alpha-Amino Acids:

    • All standard α\alpha-amino acids in proteins share a central chiral carbon atom called the α\alpha-carbon (CaC_a).

    • Bonded to the α\alpha-carbon are four distinct groups:

    1. A primary amino group (−NH3+-\text{NH}_3^+ at physiological pH≈7.4\text{pH} \approx 7.4).

    2. A carboxyl group (−COO−-\text{COO}^- at physiological pH≈7.4\text{pH} \approx 7.4).

    3. A hydrogen atom (H\text{H}).

    4. A distinctive side chain (R\text{R} group).

    • The chemical nature of the side chain (R\text{R} group) dictates the specific physical, chemical, and structural properties of the amino acid, determining protein folding, stability, and catalytic function.

  • The 20 Encoed Amino Acids and Classification:

    • Although over 500 amino acids exist in nature, the human genetic code directly encodes 20 standard amino acids (selenocysteine is considered the 21st, encoded via a specialized mRNA secondary structure mechanism).

    • Amino acids are grouped into four main chemical classes based on side chain properties:

    1. Hydrophobic Amino Acids with Nonpolar R\text{R} Groups:

      • Contain hydrocarbon side chains with an even distribution of electrons.

      • Do not gain or lose protons, nor do they participate in ionic or hydrogen bonding with water.

      • Glycine (Gly, G): Side chain =−H= -\text{H}. Smallest amino acid, achiral, highly flexible, frequently found in sharp turns and loops. DNA codons: GGT, GGC, GGA, GGG.

      • Alanine (Ala, A): Side chain =−CH3= -\text{CH}_3 (methyl group). Small, moderately hydrophobic, common in α\alpha-helices and interior cores. DNA codons: GCT, GCC, GCA, GCG.

      • Valine (Val, V): Branched-chain aliphatic (33 carbons in side chain). DNA codons: GTT, GTC, GTA, GTG.

      • Leucine (Leu, L): Branched-chain aliphatic (44 carbons in side chain). DNA codons: CTT, CTC, CTA, CTG, TTA, TTG.

      • Isoleucine (Ile, I): Branched-chain aliphatic (44 carbons in side chain, chiral β\beta-carbon). DNA codons: ATT, ATC, ATA.

      • Phenylalanine (Phe, F): Contains a bulky aromatic phenyl ring, strongly hydrophobic, buried in protein cores. DNA codons: TTT, TTC.

      • Tryptophan (Trp, W): Contains an indole ring system, large aromatic structure. DNA codon: TGG.

      • Methionine (Met, M): Contains a nonpolar thioether group (−S−-\text{S}-). Serves as the starting residue in translation. DNA codon: ATG.

      • Proline (Pro, P): Unique aliphatic cyclic structure where the side chain is covalently bonded to both the α\alpha-carbon and the backbone nitrogen atom. DNA codons: CCT, CCC, CCA, CCG.

    2. Polar Amino Acids with Neutral R\text{R} Groups:

      • Contain electronegative atoms (oxygen or sulfur) that cause uneven charge distribution, enabling hydrogen bonding with water and other polar groups.

      • Serine (Ser, S): Side chain =−CH2−OH= -\text{CH}_2-\text{OH}. Participates in hydrogen bonding and enzymatic phosphorylation. DNA codons: TCT, TCC, TCA, TCG, AGT, AGC.

      • Threonine (Thr, T): Side chain =−CH(OH)−CH3= -\text{CH}(\text{OH})-\text{CH}_3. Contains a hydroxyl group and chiral β\beta-carbon. DNA codons: ACT, ACC, ACA, ACG.

      • Tyrosine (Tyr, Y): Side chain =−CH2−(phenyl)−OH= -\text{CH}_2-(\text{phenyl})-\text{OH}. Amphipathic aromatic residue. DNA codons: TAT, TAC.

      • Cysteine (Cys, C): Side chain =−CH2−SH= -\text{CH}_2-\text{SH}. Contains a weakly polar thiol/sulfhydryl group. Two cysteine thiols undergo oxidation to form a covalent disulfide bond (−S−S−-\text{S}-\text{S}-). DNA codons: TGT, TGC.

      • Asparagine (Asn, N): Side chain =−CH2−CONH2= -\text{CH}_2-\text{CONH}_2. Carboxamide group acts as hydrogen bond donor and acceptor; site for N-linked glycosylation. DNA codons: AAT, AAC.

      • Glutamine (Gln, Q): Side chain =−CH2−CH2−CONH2= -\text{CH}_2-\text{CH}_2-\text{CONH}_2. Uncharged carboxamide group. DNA codons: CAA, CAG.

    3. Positively Charged (Basic) Amino Acids:

      • Hydrophilic side chains containing basic nitrogen atoms that are protonated and positively charged at physiological pH≈7.4\text{pH} \approx 7.4.

      • Lysine (Lys, K): Aliphatic chain terminating in a primary amino group (−NH3+-\text{NH}_3^+). pKa≈10.5\text{p}K_a \approx 10.5. DNA codons: AAA, AAG.

      • Arginine (Arg, R): Contains a guanidinium group. pKa≈12.5\text{p}K_a \approx 12.5. Strongly basic, forms salt bridges and multiple hydrogen bonds. DNA codons: CGT, CGC, CGA, CGG, AGA, AGG.

      • Histidine (His, H): Contains an aromatic imidazole ring. pKa≈6.0\text{p}K_a \approx 6.0. Can switch between protonated (++) and neutral forms near physiological pH\text{pH}, acting as a general acid-base catalyst in enzyme active sites. DNA codons: CAT, CAC.

    4. Negatively Charged (Acidic) Amino Acids:

      • Contain side chain carboxylic acid groups that deprotonate at neutral pH\text{pH} to form negatively charged carboxylates (−COO−-\text{COO}^-).

      • Aspartic Acid / Aspartate (Asp, D): Side chain =−CH2−COO−= -\text{CH}_2-\text{COO}^-. DNA codons: GAT, GAC.

      • Glutamic Acid / Glutamate (Glu, E): Side chain =−CH2−CH2−COO−= -\text{CH}_2-\text{CH}_2-\text{COO}^-. DNA codons: GAA, GAG.

Amino Acids Reference ChartGlycine and Alanine Structures
  • Ambiguous Codon Abbreviations:

    • When distinguishing between aspartate/asparagine or glutamate/glutamine is analytically difficult, special single-letter and three-letter codes are utilized:

    • Asx or B: Asparagine or Aspartate.

    • Glx or Z: Glutamine or Glutamate.

    • Xle or J: Isoleucine or Leucine.

  • Formation and Physical Properties of the Peptide Bond:

    • Amino acids are covalently linked into linear polypeptide chains via peptide bonds (amide linkages).

    • Condensation Reaction: Formed between the α\alpha-carboxyl group of one amino acid and the α\alpha-amino group of another, eliminating one molecule of H2extO\text{H}_2 ext{O}. Peptidyl transferase within the ribosome catalyzes this process during translation.

    • Resonance and Partial Double-Bond Character:

    • Delocalization of the lone pair of electrons on the amide nitrogen onto the carbonyl oxygen generates partial double-bond character along the C−N\text{C}-\text{N} peptide linkage.

    • Consequence 1: Rotation around the C−N\text{C}-\text{N} bond is restricted, locking the peptide bond into a rigid, planar geometry.

    • Consequence 2: The peptide bond is polar but uncharged; the carbonyl oxygen carries a partial negative charge (δ−\delta-) and the amide nitrogen carries a partial positive charge (δ+\delta+), allowing both to participate in backbone hydrogen bonding.

    • Consequence 3: Cis vs. Trans Configuration: The trans configuration is overwhelmingly favored (>99%> 99\%) over the cis configuration because trans minimizes steric hindrance between bulky adjacent side chains (R\text{R} groups).

  • Pathophysiological Example: Sickle Cell Disease (SCD):

    • Genetic Defect: A single nucleotide point mutation in the β\beta-globin gene (substitution of adenine for thymine, changing codon GAG to GTG).

    • Structural Consequence: Replaces a hydrophilic, negatively charged glutamate residue at position 6 of the β\beta-globin chain with a nonpolar, hydrophobic valine residue ($ ext{Glu6Val}$).

    • Molecular Mechanism: While glutamate forms ionic interactions and hydrogen bonds with water to keep hemoglobin soluble, the exposed hydrophobic valine interacts with complementary nonpolar patches on adjacent deoxyhemoglobin molecules.

    • Pathology: Causes individual hemoglobin tetramers to aggregate into long, insoluble polymer fibers that distort red blood cells into rigid, sickle-like shapes, causing microvascular occlusion, hemolysis, and severe tissue ischemia.

Levels of Protein Structure, Folding, and Dynamics

  • Primary Structure (1∘1^\circ):

    • The linear, covalent sequence of amino acids linked by peptide bonds from the N-terminus (amino end, −NH3+-\text{NH}_3^+) to the C-terminus (carboxyl end, −COO−-\text{COO}^-).

    • Encoded directly by genomic DNA; dictates all higher-order folding and final 3D protein conformation.

  • Secondary Structure (2∘2^\circ):

    • Local, spatially ordered conformations of the polypeptide backbone, stabilized by hydrogen bonds between main-chain carbonyl oxygens (−C=O-\text{C}=\text{O}) and amide nitrogens (−N−H-\text{N}-\text{H}).

    • The α\alpha-Helix:

    • A common right-handed helical rod motif where the polypeptide main chain forms the inner core, and side chains extend outward perpendicular to the helical axis.

    • Stabilization: Intrachain hydrogen bonds run parallel to the helix axis between the carbonyl oxygen of residue ii and the amide nitrogen of residue i+4i+4.

    • Parameters: 3.63.6 amino acid residues per turn; rise per residue ≈1.5 A˚\approx 1.5\,\text{\AA}; pitch per turn ≈5.4 A˚\approx 5.4\,\text{\AA}.

    • Helix Breakers and Destabilizers:

      • Proline: Referred to as the principal "helix breaker." Its cyclic side chain locks backbone dihedral angles, introducing a rigid bend/kink, and its nitrogen lacks an amide hydrogen (−N−H-\text{N}-\text{H}) to donate to the i+4i+4 hydrogen bond network.

      • Bulky/Branched Residues: Valine, Isoleucine, and Tryptophan destabilize α\alpha-helices due to steric hindrance near the β\beta-carbon.

Alpha Helix Structure
  • The β\beta-Sheet:

    • Structural motif formed by pairing two or more individual β\beta-strands, creating a pleated, extended sheet.

    • Stabilization: Interchain hydrogen bonds between adjacent strands.

    • Configurations:

      • Parallel β\beta-Sheet: Adjacent strands run in the same N-to-C terminal direction.

      • Antiparallel β\beta-Sheet: Adjacent strands run in opposite N-to-C terminal directions (yielding linear, stronger hydrogen bonds).

Beta Sheet Structure
  • Tertiary Structure (3∘3^\circ):

    • The full three-dimensional, spatial arrangement of all atoms in a single polypeptide chain, including long-range interactions between non-adjacent side chains.

    • Driving Force: The hydrophobic effect—the thermodynamic tendency of nonpolar side chains to cluster together in the protein interior, shielded from aqueous solvent, maximizing conformational entropy of surrounding water molecules.

    • Stabilizing Interactions:

    1. Hydrophobic interactions and van der Waals forces (interior packing).

    2. Hydrogen bonds (between polar side chains).

    3. Ionic bonds / Salt bridges (electrostatic attractions between oppositely charged residues like Lys+\text{Lys}^+ and Asp−\text{Asp}^-).

    4. Covalent Disulfide Bonds: Formed between oxidation of cysteine sulfhydryl (−SH-\text{SH}) groups, providing cross-linking stability.

  • Quaternary Structure (4∘4^\circ):

    • The stoichiometric and geometric assembly of multiple individual polypeptide chains (subunits) into a functional protein complex.

    • Maintained by noncovalent forces (hydrophobic packing, salt bridges, hydrogen bonds, van der Waals interactions).

    • Example: Human Hemoglobin is an α2β2\alpha_2\beta_2 heterotetramer consisting of two α\alpha-globin and two β\beta-globin subunits.

  • Structural Classes of Proteins:

    1. Globular Proteins: Compact, roughly spherical shape. Highly soluble in water. Hydrophobic residues are buried in the core; polar/charged residues reside on the surface. Act as enzymes, transporters, and regulatory factors (e.g., Hemoglobin, Myoglobin).

    2. Fibrous Proteins: Extended, elongated fiber or sheet structures. Insoluble in water. Possess highly repetitive secondary structures that provide high mechanical strength (e.g., Collagen triple helix, Keratin, Myosin).

    3. Membrane Proteins: Amphipathic proteins embedded in lipid bilayers. Nonpolar, hydrophobic residues face outward to interact with the nonpolar membrane lipid core, while polar/charged residues face aqueous intracellular/extracellular environments or internal transport channels (e.g., Ion channels, GPCRs).

Location of Amino Acids in Soluble vs Membrane Proteins
  • Thermodynamics and Energy Landscape of Protein Folding:

    • Protein folding is a directed, non-random process following specific folding pathways from high-energy unfolded states to a single native conformation.

    • Steps: Unfolded Chain →\rightarrow Secondary Structure Formation →\rightarrow Molten Globule Intermediate (compact intermediate state with partial tertiary structure) →\rightarrow Native State.

    • Energy Landscape: Visualized as a folding funnel. The native state represents the global minimum in free energy (lowest GG), making the folded state thermodynamically most stable.

Protein Denaturation, Misfolding, and Associated Pathology

  • Molecular Basis of Denaturation:

    • Denaturation is the unfolding and disruption of native 2∘,3∘,2^\circ, 3^\circ, and 4∘4^\circ structures without cleaving covalent peptide bonds (1∘1^\circ structure remains intact).

    • Results in complete loss of biological activity and loss of aqueous solubility (causing protein aggregation).

    • Denaturing Agents and Mechanisms:

    1. Heat: Increases thermal kinetic energy, disrupting weak noncovalent interactions (hydrogen bonds, van der Waals, hydrophobic packing).

      • Melting Temperature (TmT_m): The temperature at which 50%50\% of the protein molecules are folded and 50%50\% are unfolded. Thermal denaturation curves show cooperative unfolding over a narrow temperature range.

    2. Extreme pH: Low pH\text{pH} protonates carboxylates (−COO−→−COOH-\text{COO}^- \rightarrow -\text{COOH}); high pH\text{pH} deprotonates amino groups (−NH3+→−NH2-\text{NH}_3^+ \rightarrow -\text{NH}_2). Both eliminate electrostatic salt bridges and disrupt hydrogen bonds, causing unfolding via charge repulsion.

    3. Chemical Denaturants (e.g., 6−8 M6-8\,\text{M} Urea): Highly polar molecules that compete directly for backbone and side chain hydrogen bonds and solubilize nonpolar side chains, disrupting the hydrophobic core. Removal of urea via dialysis often allows spontaneous refolding into the native state (Anfinsen's experiment).

    4. Reducing Agents (e.g., β\beta-Mercaptoethanol, HS−CH2−CH2−OHHS-CH_2-CH_2-OH): Cleaves covalent disulfide bonds (−S−S−-\text{S}-\text{S}-) by reducing them back to free sulfhydryl (−SH-\text{SH}) groups, allowing total chain unfolding.

Thermal Denaturation of Egg Albumin
  • Protein Misfolding and Amyloidosis:

    • Amyloidosis: General term for diseases caused by protein misfolding, leading to soluble functional proteins undergoing an α\alpha-helix to β\beta-strand transition.

    • Aggregation Pathway: Native Monomer →\rightarrow Misfolded Intermediate (exposes hydrophobic regions) →β\rightarrow \beta-Sheet Rich Oligomers (toxic intermediate species) →\rightarrow Insoluble Amyloid Fibrillar Aggregates (plaques and tangles).

    • Diseases and Associated Amyloidogenic Proteins:

    • Alzheimer's Disease: Amyloid β\beta Peptide (AβA\beta) forms extracellular senile plaques; Tau protein forms intracellular neurofibrillary tangles.

    • Parkinson's Disease: α\alpha-Synuclein aggregates into Lewy bodies.

    • Huntington's Disease: Huntingtin with polyglutamine ($ ext{polyQ}$) expansions.

    • Amyotrophic Lateral Sclerosis (ALS): TDP-43 and SOD1 aggregates.

    • Frontotemporal Lobar Degeneration: Tau or TDP-43 misfolding.

    • Diagnostic Imaging: Positron Emission Tomography (PET) using fluorodeoxyglucose (18F-Glucose^{18}\text{F-Glucose}) reveals drastically reduced metabolic activity in affected brain regions in Alzheimer's patients due to synaptic loss and neurodegeneration.

Amyloidosis Structural Basis

Digestion and Absorption of Dietary Macromolecules

  • Overview of Dietary Cleavage:

    • Macromolecules are polymers constructed via condensation reactions. Digestion uses hydrolase enzymes to add water molecules ($ ext{H}_2 ext{O}$) and cleave covalent bonds (hydrolysis).

  • Protein Digestion and Specific Absorption:

    • Stomach Phase:

    • Hydrochloric Acid (HCl): Secreted by parietal cells in gastric glands. Lowers gastric pH\text{pH} to 1.5−3.51.5-3.5, denaturing tertiary structures to expose peptide bonds.

    • Pepsin: Secreted as inactive zymogen pepsinogen by gastric chief cells. Low pH\text{pH} induces autocatalytic cleavage of pepsinogen to active pepsin. Pepsin cleaves interior peptide bonds to generate large polypeptide fragments.

    • Small Intestinal Lumen Phase:

    • Low pH\text{pH} chyme enters the duodenum, triggering pancreatic secretion of zymogens and bicarbonate.

    • Enteropeptidase (bound to brush border membrane) cleaves trypsinogen into active trypsin.

    • Trypsin Cascade: Active trypsin cleaves and activates all other pancreatic zymogens:

      • Trypsinogen →\rightarrow Trypsin.

      • Chymotrypsinogen →\rightarrow Chymotrypsin.

      • Proelastase →\rightarrow Elastase.

      • Procarboxypeptidases A/B →\rightarrow Carboxypeptidases A/B.

    • Protease Cleavage Specificities:

      • Trypsin (Endopeptidase): Cleaves carboxyl side of basic, positively charged residues (Arg, Lys).

      • Chymotrypsin (Endopeptidase): Cleaves carboxyl side of bulky hydrophobic residues (Trp, Tyr, Phe, Met, Leu).

      • Elastase (Endopeptidase): Cleaves carboxyl side of small residues (Ala, Gly, Ser).

      • Carboxypeptidase A (Exopeptidase): Removes C-terminal hydrophobic residues (Ala, Ile, Leu, Val).

      • Carboxypeptidase B (Exopeptidase): Removes C-terminal basic residues (Arg, Lys).

    • Brush Border and Absorption:

    • Brush border membrane peptidases (aminopeptidases, endopeptidases, di/tripeptidases) finish cleaving oligopeptides into free amino acids, dipeptides, and tripeptides.

    • Free amino acids are absorbed across the apical membrane via Na+Na^+-dependent amino acid symporters (e.g., System B0\text{B}^0, B0+B^{0+}), driven by the sodium gradient maintained by basolateral Na+/K+Na^+/K^+-ATPase pumps.

    • Free amino acids leave enterocytes across the basolateral membrane down concentration gradients via facilitated transporters into capillaries, traveling to the liver via the portal vein.

Protein Breakdown in the GI Tract
  • Inborn Errors of Amino Acid Transporters:

    1. Hartnup Disease:

    • Cause: Autosomal recessive mutation in the SLC6A19SLC6A19 gene encoding the Na+Na^+-dependent neutral amino acid transporter (B0extAT1B^0 ext{AT1}) in the intestine and renal proximal tubules.

    • Pathophysiology: Impaired absorption and reabsorption of nonpolar/neutral amino acids, particularly Tryptophan.

    • Clinical Manifestation: Tryptophan deficiency limits synthesis of Niacin (Vitamin B3B_3), leading to Pellagra-like symptoms (The 3 Ds): Dermatitis, Dementia, Diarrhea.

    1. Cystinuria:

    • Cause: Defect in reabsorption of dibasic amino acids (Lysine, Ornithine, Arginine) and Cystine in renal proximal tubules.

    • Pathophysiology: Cystine is a disulfide-linked dimer of two cysteines with extremely low water solubility (0.112 mg/mL0.112\,\text{mg/mL} at 25∘C25^\circ\text{C} compared to 25 mg/mL25\,\text{mg/mL} for cysteine). Unabsorbed cystine concentrates in urine and precipitates, forming recurrent cystine kidney stones (calculi).

  • Carbohydrate Digestion and Monosaccharide Uptake:

    • Starch & Glycogen Digestion:

    • Salivary and Pancreatic α\alpha-Amylase: Endoglycosidase that hydrolyzes internal α−1,4\alpha-1,4-glycosidic bonds. Cannot cleave branch-point α−1,6\alpha-1,6-glycosidic bonds or terminal bonds.

    • Products: Disaccharide maltose, trisaccharide maltotriose, and branched α\alpha-limit dextrins.

    • Brush Border Disaccharidases:

      • Maltase: Cleaves maltose →2\rightarrow 2 Glucose.

      • Lactase: Cleaves lactose →\rightarrow Galactose ++ Glucose.

      • Sucrase: Cleaves sucrose →\rightarrow Glucose ++ Fructose.

      • \alpha-Dextrinase / Isomaltase: Cleaves α−1,6\alpha-1,6-glycosidic branch points.

    • Cellulose Incompatibility: Humans lack cellulase (which hydrolyzes β−1,4\beta-1,4-glycosidic linkages of cellulose); dietary fiber passes unabsorbed.

    • Monosaccharide Uptake Mechanisms:

    • Apical Transport:

      • Glucose and Galactose: Transported into enterocytes via SGLT1 (Na+Na^+-glucose cotransporter 1) using secondary active transport.

      • Fructose: Transported via GLUT5 via facilitated diffusion.

    • Basolateral Exit: All three monosaccharides exit enterocytes into capillaries via GLUT2.

    • Lactose Intolerance:

    • Mechanism: Age-dependent silencing of the lactase gene (prevalent in 90%90\% of adults of African or Asian descent) leads to lactase deficiency.

    • Pathology: Undigested lactose passes into the large intestine where colonic bacteria ferment it into 22-carbon and 33-carbon short-chain fatty acids, CO2CO_2, and $ ext{H}_2$ gas.

    • Symptoms: Osmotic draw of water causes bloating, cramps, and diarrhea. Hydrogen gas diffuses into blood and is measured in the breath ($ ext{H}_2$ breath test).

Monosaccharide Transport Across EnterocytePathophysiology of Lactose Intolerance
  • Lipid Digestion, Emulsification, and Chylomicron Metabolism:

    • Mouth and Stomach: Lingual and gastric lipases hydrolyze short- and medium-chain fatty acids (≤12\le 12 carbons) from triacylglycerols (TAGs); vital in infants consuming milk.

    • Duodenal Emulsification: Mechanical peristaltic churning combined with amphipathic bile salts (conjugated bile acids such as glycocholic acid, pKa=4\text{p}K_a=4, and taurocholic acid, pKa=2\text{p}K_a=2) emulsify large fat globules into small droplets, increasing surface area for enzymatic attack.

    • Pancreatic Enzymatic Cleavage:

    • Pancreatic Lipase + Colipase: Hydrolyzes TAGs at C1C_1 and C3C_3 positions →2\rightarrow 2-Monoacylglycerol (2-MAG) ++ 22 Free Fatty Acids (FFAs).

    • Cholesterol Esterase: Hydrolyzes cholesteryl esters →\rightarrow Free cholesterol ++ FFA.

    • Phospholipase A2A_2: Hydrolyzes phospholipids →\rightarrow Lysophospholipids ++ FFA.

    • Micelle Formation and Absorption: Hydrophobic products aggregate with bile salts to form mixed micelles, which diffuse across the unstirred water layer to the enterocyte brush border, releasing lipids for passive uptake.

    • Re-esterification & Chylomicron Assembly:

    • Inside enterocytes, fatty acids are re-esterified with 2-MAG to reform TAGs, and cholesterol is re-esterified to cholesteryl esters.

    • Lipids are packaged into Nascent Chylomicrons containing core TAG (90%90\%) and Cholesteryl Esters, coated by a monolayer of phospholipids, unesterified cholesterol, and Apolipoprotein B-48 (ApoB-48).

    • Exocytosed into lymphatic lacteals →\rightarrow thoracic duct $ ightarrow$ systemic circulation.

    • Maturation and Clearance:

    • Nascent chylomicrons acquire ApoC-II and ApoE from circulating High-Density Lipoproteins (HDL).

    • ApoC-II activates Lipoprotein Lipase (LPL) on capillary endothelial walls of adipose and muscle tissues, hydrolyzing TAGs into free fatty acids for energy or storage.

    • ApoE binds hepatic receptors, mediating liver uptake of chylomicron remnants.

    • Steatorrhea: Excretion of excess fat in feces caused by lipid malabsorption (biliary obstruction, chronic pancreatitis, cystic fibrosis CFTR channel mutations thickening secretions, or Inflammatory Bowel Disease).

  • Hormonal Regulation of Digestion:

    • Secretin: Released by intestinal cells in response to acidic chyme (low pHlow\,\text{pH}). Stimulates pancreatic acinar cells to secrete bicarbonate (NaHCO3NaHCO_3), neutralizing stomach acid.

    • Cholecystokinin (CCK): Released by intestinal cells in response to dietary peptides and fatty acids. Stimulates gallbladder contraction (releasing bile salts), pancreatic enzyme secretion, and enteropeptidase synthesis.

Nitrogen Catabolism: Transamination, Deamination, and the Urea Cycle

  • Nitrogen Balance and Removal Rationale:

    • Daily human nitrogen turnover involves ≈100 g/day\approx 100\,\text{g/day} dietary protein input and ≈400 g/day\approx 400\,\text{g/day} endogenous protein turnover.

    • Amino acids cannot be stored. Excess amino acids are degraded; nitrogen must be removed first because free ammonia (NH3/NH4+\text{NH}_3/\text{NH}_4^+) is neurotoxic.

  • Step 1: Transamination:

    • Reaction: Transfers the α\alpha-amino group of an amino acid to an α\alpha-keto acid recipient (usually α\alpha-ketoglutarate), converting the original amino acid into its corresponding α\alpha-keto acid and α\alpha-ketoglutarate into glutamate.

    • Enzymes: Aminotransferases / Transaminases.

    • Co-enzyme: Pyridoxal Phosphate (PLP), derived from Vitamin B6B_6.

    • Diagnostic Biomarkers:

    • Alanine Aminotransferase (ALT): Converts Alanine ++ α\alpha-Ketoglutarate ⇌\rightleftharpoons Pyruvate ++ Glutamate. Predominantly localized in the liver; elevated serum ALT is a highly specific marker for hepatic necrosis (e.g., Hepatitis C).

    • Aspartate Aminotransferase (AST): Converts Aspartate ++ α\alpha-Ketoglutarate ⇌\rightleftharpoons Oxaloacetate ++ Glutamate. Present in liver, heart, skeletal muscle, and brain; elevated in myocardial infarction and muscle trauma.

Transamination ALT and AST
  • Step 2: Oxidative Deamination:

    • Enzyme: Glutamate Dehydrogenase (GDH), located in the mitochondrial matrix of liver and kidney cells.

    • Reaction: Converts Glutamate +NAD+(or NADP+)+H2O⇌α-Ketoglutarate+NADH (or NADPH)+H++NH4++\text{NAD}^+ (\text{or NADP}^+) + \text{H}_2\text{O} \rightleftharpoons \alpha\text{-Ketoglutarate} + \text{NADH (or NADPH)} + \text{H}^+ + \text{NH}_4^+.

    • Allosteric Regulation: Inhibited by high energy charge (GTP, ATP); activated by low energy charge (ADP, GDP).

    • Releases toxic ammonium ion (NH4+\text{NH}_4^+), which is immediately funneled into urea synthesis.

  • Ammonia Fixation Reactions:

    • Three main physiological reactions fix free ammonia into organic molecules:

    1. α-Ketoglutarate+NH4++NADPH→GDHGlutamate+NADP++H2O\alpha\text{-Ketoglutarate} + \text{NH}_4^+ + \text{NADPH} \xrightarrow{\text{GDH}} \text{Glutamate} + \text{NADP}^+ + \text{H}_2\text{O}.

    2. Glutamate+NH4++ATP→Glutamine SynthetaseGlutamine+ADP+Pi\text{Glutamate} + \text{NH}_4^+ + \text{ATP} \xrightarrow{\text{Glutamine Synthetase}} \text{Glutamine} + \text{ADP} + P_i.

    3. HCO3−+NH4++2 ATP→CPSICarbamoyl Phosphate+2 ADP+Pi\text{HCO}_3^- + \text{NH}_4^+ + 2\text{ ATP} \xrightarrow{\text{CPSI}} \text{Carbamoyl Phosphate} + 2\text{ ADP} + P_i.

  • The Urea Cycle (Krebs-Henseleit Cycle):

    • Converts toxic ammonia into non-toxic, highly soluble urea in the liver (90%90\% of urinary nitrogen excretion).

    • Compartmentalization: Steps 1-2 occur in the mitochondrial matrix; Steps 3-5 occur in the cytosol.

Urea Cycle Overview Diagram
  • Detailed Enzymatic Steps:

    1. Formation of Carbamoyl Phosphate (Mitochondria):

      • HCO3−+NH4++2 ATP→Carbamoyl Phosphate Synthetase I (CPSI)Carbamoyl Phosphate+2 ADP+Pi\text{HCO}_3^- + \text{NH}_4^+ + 2\text{ ATP} \xrightarrow{\text{Carbamoyl Phosphate Synthetase I (CPSI)}} \text{Carbamoyl Phosphate} + 2\text{ ADP} + P_i.

      • Rate-limiting step. Requires NN-acetylglutamate (NAG) as an essential allosteric activator.

      • Incorporates the first nitrogen atom of urea (derived from free NH4+\text{NH}_4^+).

    2. Formation of Citrulline (Mitochondria):

      • Carbamoyl Phosphate+Ornithine→Ornithine Transcarbamoylase (OTC)Citrulline+Pi\text{Carbamoyl Phosphate} + \text{Ornithine} \xrightarrow{\text{Ornithine Transcarbamoylase (OTC)}} \text{Citrulline} + P_i.

      • Citrulline is transported out of the mitochondria into the cytosol via a specific transporter.

    3. Formation of Argininosuccinate (Cytosol):

      • Citrulline+Aspartate+ATP→Argininosuccinate SynthetaseArgininosuccinate+AMP+PPi\text{Citrulline} + \text{Aspartate} + \text{ATP} \xrightarrow{\text{Argininosuccinate Synthetase}} \text{Argininosuccinate} + \text{AMP} + PP_i.

      • Incorporates the second nitrogen atom of urea (derived from Aspartate).

    4. Cleavage of Argininosuccinate (Cytosol):

      • Argininosuccinate→Argininosuccinate LyaseArginine+Fumarate\text{Argininosuccinate} \xrightarrow{\text{Argininosuccinate Lyase}} \text{Arginine} + \text{Fumarate}.

      • Fumarate enters the TCA cycle (linking the Urea Cycle to carbohydrate metabolism via the "Krebs Bicycle").

    5. Cleavage of Arginine to Urea and Ornithine (Cytosol):

      • Arginine+H2O→ArginaseUrea+Ornithine\text{Arginine} + \text{H}_2\text{O} \xrightarrow{\text{Arginase}} \text{Urea} + \text{Ornithine}.

      • Arginase is expressed exclusively in the liver. Ornithine is transported back into the mitochondrion to restart the cycle.

  • Overall Stoichiometry:     CO2+NH4++3 ATP+Aspartate+2 H2O→Urea+2 ADP+2 Pi+AMP+PPi+Fumarate\text{CO}_2 + \text{NH}_4^+ + 3\text{ ATP} + \text{Aspartate} + 2\text{ H}_2\text{O} \rightarrow \text{Urea} + 2\text{ ADP} + 2\text{ }P_i + \text{AMP} + PP_i + \text{Fumarate}

  • Consumes 44 high-energy phosphate bonds (due to ATP→AMP+PPi\text{ATP} \rightarrow \text{AMP} + PP_i in Step 3), making urea synthesis thermodynamically irreversible.

  • Normal Blood Urea Nitrogen (BUN): 7−21 mg/dL7 - 21\,\text{mg/dL}.

    • Nitrogen Adaptation in Hibernating Bears:

  • Bears fast for months without urinating. Urea is produced in the liver, filtered into the bladder, reabsorbed through epithelial aquaporin/urea channels into blood, and passed into the gut lumen.

  • Intestinal bacteria express urease, hydrolyzing urea into NH3+CO2\text{NH}_3 + \text{CO}_2. Bear tissues utilize NH4+\text{NH}_4^+ to re-synthesize nonessential amino acids and preserve total muscle mass.

    • Biological Atmospheric Nitrogen Fixation:

  • Atmospheric nitrogen ($ ext{N}_2$) is inert due to a triple bond (N≡NN \equiv N).

  • Fixed into biological ammonia by prokaryotic diazotrophs (e.g., Rhizobium in leguminous plant root nodules) using the Nitrogenase Complex.

  • Complex Subunits:

    1. Reductase (Fe Protein): Transfers high-energy electrons from reduced ferredoxin to nitrogenase in an ATP-dependent manner.

    2. Nitrogenase (MoFe Protein): Uses electrons to reduce N2→2 NH3\text{N}_2 \rightarrow 2\text{ }\text{NH}_3.

  • Net Reaction:     N2+8e−+8 H++16 ATP+16 H2O→2 NH3+H2+16 ADP+16 Pi\text{N}_2 + 8 e^- + 8\text{ H}^+ + 16\text{ ATP} + 16\text{ H}_2\text{O} \rightarrow 2\text{ }\text{NH}_3 + \text{H}_2 + 16\text{ ADP} + 16\text{ }P_i

Nitrogenase Complex Reactions

Catabolism of Carbon Skeletons and Inborn Errors of Amino Acid Metabolism

  • Glucogenic vs. Ketogenic Classification:

    • Carbon skeletons of degraded amino acids converge onto 7 major metabolic intermediates:

    1. Glucogenic: Yield pyruvate, α\alpha-ketoglutarate, succinyl-CoA, fumarate, or oxaloacetate (precursors for gluconeogenesis).

      • Purely Glucogenic: Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Pro, Ser, Val, Met, Thr.

    2. Ketogenic: Yield acetoacetate, acetyl-CoA, or acetoacetyl-CoA (precursors for ketone bodies and fatty acids).

      • Purely Ketogenic: Leucine and Lysine.

    3. Both Glucogenic and Ketogenic: Yield glucogenic and ketogenic products (Isoleucine, Phenylalanine, Tryptophan, Tyrosine).

Glucogenic vs Ketogenic Classification
  • Pathways of Degradation and Metabolic Disorders:

    • Amino Acids Degraded to Pyruvate:

    • Alanine: Transaminated by ALT to Pyruvate.

    • Serine: Deaminated by Serine Dehydratase →Pyruvate+NH4+\rightarrow \text{Pyruvate} + \text{NH}_4^+.

    • Glycine: Interconverted with Serine via Serine Hydroxymethyltransferase (SHMT) using N5,N10N^5,N^{10}-Methylene-THF.

    • Amino Acids Degraded to Oxaloacetate:

    • Asparagine →AsparaginaseAspartate+NH4+\xrightarrow{\text{Asparaginase}} \text{Aspartate} + \text{NH}_4^+.

    • Aspartate →ASTOxaloacetate\xrightarrow{\text{AST}} \text{Oxaloacetate}.

    • Amino Acids Degraded to α\alpha-Ketoglutarate:

    • Gln, Pro, Arg, and His degrade to Glutamate, which is converted by GDH to α\alpha-ketoglutarate.

    • Phenylalanine and Tyrosine Degradation & Disorders:

    • Pathway: Phenylalanine →PAH + BH4Tyrosine→TATp-Hydroxyphenylpyruvate→Homogentisate→Homogentisate OxidaseFumarylacetoacetate→Fumarate+Acetoacetate\xrightarrow{\text{PAH + }BH_4} \text{Tyrosine} \xrightarrow{\text{TAT}} p\text{-Hydroxyphenylpyruvate} \rightarrow \text{Homogentisate} \xrightarrow{\text{Homogentisate Oxidase}} \text{Fumarylacetoacetate} \rightarrow \text{Fumarate} + \text{Acetoacetate}.

    • Phenylketonuria (PKU):

      • Cause: Deficiency in Phenylalanine Hydroxylase (PAH) or co-factor Tetrahydrobiopterin (BH4BH_4).

      • Pathophysiology: Phenylalanine accumulates and transaminates to phenylpyruvate, phenyllactate, and phenylacetate (excreted in urine, giving a characteristic musty/mousy odor).

      • Clinical Effect: High Phe is neurotoxic, causing irreversible intellectual disability and hypopigmentation (lack of Tyrosine for melanin).

      • Treatment: Low-phenylalanine diet, avoid aspartame, Tyrosine supplementation (Tyrosine becomes essential).

    • Alcaptonuria: Deficiency of homogentisate oxidase; homogentisic acid accumulates, turning urine black upon oxidation, causing ochronosis (dark connective tissue) and arthritis.

    • Albinism: Deficiency of tyrosinase; blocks melanin synthesis from tyrosine.

    • Branched-Chain Amino Acid (BCAA) Degradation & Disorder:

    • BCAAs (Leucine, Isoleucine, Valine) undergo transamination by Branched-Chain Aminotransferase, followed by oxidative decarboxylation catalyzed by Branched-Chain α\alpha-Keto Acid Dehydrogenase (BCKAD).

    • Maple Syrup Urine Disease (MSUD):

      • Cause: Defect in the multienzyme complex BCKAD.

      • Pathophysiology: Accumulation of BCAAs and their toxic α\alpha-keto acid derivatives in blood, tissues, and urine.

      • Symptoms: Sweet "maple syrup" odor of urine/sweat, severe ketoacidosis, vomiting, lethargy, and neurological destruction.

      • Treatment: Lifelong dietary restriction of Valine, Isoleucine, and Leucine.

    • Methionine Degradation and Homocysteine Metabolism:

    • Methionine +ATP→S-Adenosylmethionine (SAM)+ \text{ATP} \rightarrow S\text{-Adenosylmethionine (SAM)}. SAM donates a methyl group (-CH3\text{-CH}_3) to acceptors, converting to SS-Adenosylhomocysteine (SAH), then to Homocysteine.

    • Two Disposal Pathways for Homocysteine:

      1. Transsulfuration to Cysteine (Glucogenic pathway):

      • Homocysteine+Serine→Cystathionine β-synthase (CBS)+PLP (Vit B6)Cystathionine→PLPCysteine+α-Ketobutyrate→Propionyl-CoA→BiotinD-Methylmalonyl-CoA→Vit B12Succinyl-CoA\text{Homocysteine} + \text{Serine} \xrightarrow{\text{Cystathionine } \beta\text{-synthase (CBS)} + \text{PLP (Vit } B_6)} \text{Cystathionine} \xrightarrow{\text{PLP}} \text{Cysteine} + \alpha\text{-Ketobutyrate} \rightarrow \text{Propionyl-CoA} \xrightarrow{\text{Biotin}} \text{D-Methylmalonyl-CoA} \xrightarrow{\text{Vit } B_{12}} \text{Succinyl-CoA}.

      1. Remethylation to Methionine:

      • Homocysteine+N5-Methyl-THF→Methionine Synthase+Methyl-B12Methionine+THF\text{Homocysteine} + N^5\text{-Methyl-THF} \xrightarrow{\text{Methionine Synthase} + \text{Methyl-}B_{12}} \text{Methionine} + \text{THF}.

    • Clinical Indicator: Accumulation of methylmalonic acid in serum/urine specifically indicates Vitamin B12B_{12} deficiency (due to defect in Methylmalonyl-CoA Mutase).

Nucleotide Structure, De Novo Synthesis, and Salvage Pathways

  • Nucleotide Components and Chemistry:

    • Nucleoside =Nitrogenous Base+Pentose Sugar= \text{Nitrogenous Base} + \text{Pentose Sugar}.

    • Nucleotide =Nitrogenous Base+Pentose Sugar+1,2,or 3 Phosphate Groups= \text{Nitrogenous Base} + \text{Pentose Sugar} + 1, 2, \text{or } 3 \text{ Phosphate Groups}.

    • Bases:

    • Purines (two fused rings): Adenine (A), Guanine (G).

    • Pyrimidines (single ring): Cytosine (C), Thymine (T, DNA only), Uracil (U, RNA only).

    • Sugars: Ribose (2′−OH2'-\text{OH} present in RNA); Deoxyribose (2′−H2'-\text{H} lacking oxygen in DNA).

    • Phosphates: Attached at 5′5' carbon of sugar; designated α,β,γ\alpha, \beta, \gamma.

  • De Novo Purine Biosynthesis:

    • Builds the purine ring directly onto a pre-existing Ribose 5-Phosphate frame in the cytosol.

    • Step 1: Activation of Ribose 5-Phosphate:

    • Ribose 5-Phosphate+ATP→PRPP Synthetase5-Phosphoribosyl 1-Pyrophosphate (PRPP)+AMP\text{Ribose 5-Phosphate} + \text{ATP} \xrightarrow{\text{PRPP Synthetase}} \text{5-Phosphoribosyl 1-Pyrophosphate (PRPP)} + \text{AMP}.

    • Step 2: Committed and Rate-Limiting Step:

    • PRPP+Glutamine+H2O→Glutamine PRPP Amidotransferase5-Phosphoribosyl 1-Amine+Glutamate+PPi\text{PRPP} + \text{Glutamine} + \text{H}_2\text{O} \xrightarrow{\text{Glutamine PRPP Amidotransferase}} \text{5-Phosphoribosyl 1-Amine} + \text{Glutamate} + PP_i.

    • Ring Assembly:

    • The purine ring atoms are contributed by:

      • Glycine: C4,C5,N7C_4, C_5, N_7.

      • N10N^{10}-Formyl-THF: C2,C8C_2, C_8.

      • Glutamine (amide N): N3,N9N_3, N_9.

      • Aspartate: N1N_1.

      • CO2\text{CO}_2 (Bicarbonate): C6C_6.

    • Formation of IMP and Branching:

    • Intermediate generated is Inosine Monophosphate (IMP) (base is Hypoxanthine).

    • IMP →\rightarrow AMP: Requires Aspartate and energy input from GTP.

    • IMP →\rightarrow GMP: Requires Glutamine and energy input from ATP.

    • Regulation: PRPP Synthetase and Glutamine PRPP Amidotransferase are feedback-inhibited by end-products (AMP, GMP, IMP, ADP, GDP, ATP, GTP).

  • Purine Salvage Pathways (90%90\% of Cellular Needs):

    • Recycles preformed purine bases generated from RNA/DNA breakdown or diet, attaching them to PRPP.

    • Enzymes:

    1. Adenine Phosphoribosyltransferase (APRT): Adenine+PRPP→AMP+PPi\text{Adenine} + \text{PRPP} \rightarrow \text{AMP} + PP_i.

    2. Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT):

      • Hypoxanthine+PRPP→IMP+PPi\text{Hypoxanthine} + \text{PRPP} \rightarrow \text{IMP} + PP_i.

      • Guanine+PRPP→GMP+PPi\text{Guanine} + \text{PRPP} \rightarrow \text{GMP} + PP_i.

    • Lesch-Nyhan Syndrome:

    • Cause: X-linked recessive total deficiency of HGPRT.

    • Pathophysiology: Hypoxanthine and Guanine cannot be salvaged; PRPP accumulates, hyper-activating de novo purine synthesis. Excess purines degrade into massive quantities of uric acid.

    • Clinical Features: Severe hyperuricemia, gout, kidney stones, intellectual disability, choreoathetosis, and characteristic involuntary self-mutilation (biting lips and fingers).

  • Purine Degradation and Gout:

    • Pathway: AMP →\rightarrow Adenosine →Adenosine Deaminase (ADA)Inosine→Hypoxanthine\xrightarrow{\text{Adenosine Deaminase (ADA)}} \text{Inosine} \rightarrow \text{Hypoxanthine}. GMP →\rightarrow Guanosine →Guanine→Xanthine\rightarrow \text{Guanine} \rightarrow \text{Xanthine}.

    • Xanthine Oxidase (XO): Converts Hypoxanthine →\rightarrow Xanthine →\rightarrow Uric Acid.

    • Severe Combined Immunodeficiency (SCID):

    • Cause: Autosomal recessive deficiency of Adenosine Deaminase (ADA).

    • Pathophysiology: Loss of ADA causes accumulation of deoxyadenosine, which is phosphorylated to high levels of dATP. Excess dATP allosterically inhibits Ribonucleotide Reductase (RR), blocking synthesis of all dNTPs. DNA replication halts, inducing apoptosis of proliferating T and B lymphocytes.

    • Gout:

    • Cause: Hyperuricemia (plasma urate >6.8 mg/dL> 6.8\,\text{mg/dL}) due to purine overproduction or renal underexcretion.

    • Pathology: Monosodium urate crystals precipitate in joints (triggering painful acute inflammatory arthritis/tophi) and kidney tubules.

    • Pharmacological Interventions:

      • Allopurinol: Structural analog of hypoxanthine; competitive/suicide inhibitor of Xanthine Oxidase, lowering uric acid production.

      • Febuxostat: Non-purine selective inhibitor of Xanthine Oxidase.

      • Colchicine / NSAIDs: Anti-inflammatory agents for acute gout attacks.

      • Probenecid: Uricosuric agent that increases renal excretion of uric acid.

Degradation of Purine Nucleotides to Uric Acid

Pyrimidine Synthesis, Degradation, and Chemotherapeutic Interventions

  • De Novo Pyrimidine Biosynthesis:

    • Unlike purines, the pyrimidine ring is synthesized first as free orotic acid and then attached to PRPP.

    • Ring Atoms Source:

    • Bicarbonate (CO2\text{CO}_2): C2C_2.

    • Glutamine: N3N_3.

    • Aspartate: N1,C4,C5,C6N_1, C_4, C_5, C_6.

    • Step 1: Synthesis of Carbamoyl Phosphate:

    • Glutamine+CO2+2 ATP→CPS-IICarbamoyl Phosphate+Glutamate+2 ADP+Pi\text{Glutamine} + \text{CO}_2 + 2\text{ ATP} \xrightarrow{\text{CPS-II}} \text{Carbamoyl Phosphate} + \text{Glutamate} + 2\text{ ADP} + P_i.

    • Carbamoyl Phosphate Synthetase II (CPS-II) is cytosolic (unlike mitochondrial CPSI of the urea cycle). Inhibited by UTP; activated by PRPP.

    • The CAD Multienzyme Complex: In eukaryotes, the first three enzymatic steps are catalyzed by a single trifunctional polypeptide named CAD:

    1. C: Carbamoyl Phosphate Synthetase II.

    2. A: Aspartate Transcarbamoylase (ATCase).

    3. D: Dihydroorotase.

    • Formation of UMP:

    • Dihydroorotate is oxidized to Orotate by Dihydroorotate Dehydrogenase.

    • UMP Synthase: A bifunctional enzyme containing:

      1. Orotate Phosphoribosyltransferase (OPRT): Attaches PRPP to Orotate →\rightarrow Orotidylate (OMP).

      2. Orotidylate Decarboxylase (ODCase): Decarboxylates OMP →\rightarrow Uridine Monophosphate (UMP).

    • Conversion to CTP and dTMP:

    • UMP→UDP→UTP→CTP Synthetase + GlnCTP\text{UMP} \rightarrow \text{UDP} \rightarrow \text{UTP} \xrightarrow{\text{CTP Synthetase } + \text{ Gln}} \text{CTP}.

    • Ribonucleotide Reductase (RR): Converts UDP to dUDP, which is converted to dUMP.

    • Thymidylate Synthase: Converts dUMP+N5,N10-Methylene-THF→dTMP+Dihydrofolate (DHF)\text{dUMP} + N^5,N^{10}\text{-Methylene-THF} \rightarrow \text{dTMP} + \text{Dihydrofolate (DHF)}.

  • Chemotherapeutic and Antimicrobial Targets:

    1. 5-Fluorouracil (5-FU): Converted intracellularly to 5-FdUMP5\text{-FdUMP}, an irreversible suicide inhibitor of Thymidylate Synthase, blocking dTMP synthesis and halting cancer cell DNA replication.

    2. Methotrexate (MTX): Competitive structural inhibitor of Dihydrofolate Reductase (DHFR). Prevents regeneration of THF from DHF, depleting N5,N10N^5,N^{10}-methylene-THF and N10N^{10}-formyl-THF pools, inhibiting both dTMP and de novo purine synthesis.

    3. Hydroxyurea: Inhibits Ribonucleotide Reductase (RR), blocking conversion of NDPs to dNDPs, depleting dNTP pools.

    4. Mycophenolic Acid: Reversible, uncompetitive inhibitor of IMP Dehydrogenase, depleting GMP/GTP needed for T and B lymphocyte proliferation (used as an immunosuppressant to prevent transplant rejection).

    5. Azathioprine: Purine analog prodrug converted to 66-mercaptopurine, inhibiting de novo purine synthesis.

    6. Sulfonamides (e.g., Sulfamethoxazole): Structural analogs of pp-aminobenzoic acid (PABA). Competitively inhibit Dihydropteroate Synthetase (DHPS) in bacteria. Bacteria must synthesize folate de novo, whereas humans absorb dietary folate (lacking DHPS), granting selective bacterial toxicity.

Folate Metabolism, the One-Carbon Pool, and Vitamin B12B_{12} Interdependence

  • Folate Structure and Activation:

    • Folate (Vitamin B9B_9): Consists of a pteridine ring, pp-aminobenzoic acid (PABA), and a polyglutamate tail.

    • Reduction: Folic acid/folate is reduced in two successive NADPH-dependent steps by Dihydrofolate Reductase (DHFR):     Folate→DHFR + NADPHDihydrofolate (DHF)→DHFR + NADPHTetrahydrofolate (THF/FH4)\text{Folate} \xrightarrow{\text{DHFR + NADPH}} \text{Dihydrofolate (DHF)} \xrightarrow{\text{DHFR + NADPH}} \text{Tetrahydrofolate (THF/FH}_4\text{)}

    • Active Coenzyme: THF serves as the universal carrier of one-carbon (1C1\text{C}) groups.

  • One-Carbon Oxidation States and Transfer Roles:

    • 1C1\text{C} units attach to nitrogens N5N^5, N10N^{10}, or bridge both (N5,N10N^5,N^{10}):

    1. Methyl (-CH<em>3\text{-CH}<em>3): Most reduced state (N5-Methyl-THFN^5\text{-Methyl-THF}). Donates methyl group to Vitamin B</em>12B</em>{12} for methionine synthesis.

    2. Methylene (−CH2−-\text{CH}_2-): Intermediate oxidation state (N5,N10-Methylene-THFN^5,N^{10}\text{-Methylene-THF}). Donates methyl group to dUMP for dTMP synthesis; interconverts serine and glycine.

    3. Formyl (−CHO-\text{CHO}): Most oxidized state (N10-Formyl-THFN^{10}\text{-Formyl-THF}). Donates C2C_2 and C8C_8 carbons during de novo purine synthesis.

    4. Formimino (−CHNH-\text{CHNH}): Generated during Histidine catabolism (N5-Formimino-THFN^5\text{-Formimino-THF}).

    • Primary One-Carbon Donor: Serine is the major physiological donor of one-carbon units in humans via Serine Hydroxymethyltransferase (SHMT).

Folate and One Carbon Pool Integration
  • Histidine Catabolism and the FIGLU Test:

    • Pathway: Histidine →HistidaseUrocanate→4-Imidazolone-5-propionate→N-Formiminoglutamate (FIGLU)\xrightarrow{\text{Histidase}} \text{Urocanate} \rightarrow \text{4-Imidazolone-5-propionate} \rightarrow N\text{-Formiminoglutamate (FIGLU)}.

    • THF Dependency: FIGLU+THF→Formimino-transferaseGlutamate+N5-Formimino-THF\text{FIGLU} + \text{THF} \xrightarrow{\text{Formimino-transferase}} \text{Glutamate} + N^5\text{-Formimino-THF}.

    • The FIGLU Test: Patients are given an oral histidine load. In folate or Vitamin B12B_{12} deficiency, THF is deficient, blocking FIGLU breakdown. Unmetabolized FIGLU accumulates and is excreted in urine, serving as a clinical diagnostic marker for folate deficiency.

  • Vitamin B12B_{12} Deficiency and the Methyl-Folate Trap:

    • Methionine Synthase Reaction: Homocysteine+N5-Methyl-THF→Methionine Synthase + Methyl-B12Methionine+THF\text{Homocysteine} + N^5\text{-Methyl-THF} \xrightarrow{\text{Methionine Synthase } + \text{ Methyl-}B_{12}} \text{Methionine} + \text{THF}.

    • The Trap Mechanism: The reduction of N5,N10N^5,N^{10}-Methylene-THF to N5N^5-Methyl-THF is irreversible. The only pathway to reoxidize N5N^5-Methyl-THF back into usable THF is the Vitamin B12B_{12}-dependent Methionine Synthase reaction.

    • Consequence: When Vitamin B12B_{12} is deficient, Methionine Synthase is inactive. Body folate becomes irreversibly trapped as N5N^5-Methyl-THF. This creates a functional THF deficiency, halting N10N^{10}-formyl-THF and N5,N10N^5,N^{10}-methylene-THF generation, disrupting purine and dTMP synthesis, and resulting in Megaloblastic Anemia.

Mitochondrial Electron Transport Chain and Chemiosmosis

  • Mitochondrial Architecture:

    • Outer Membrane: Contains large porin channels, freely permeable to small molecules and ions (<5000 Da< 5000\,\text{Da}).

    • Intermembrane Space: Highly concentrated in protons (H+H^+) during active respiratory electron transport; contains soluble cytochrome cc.

    • Inner Membrane: Impermeable to small molecules, ions, H+H^+, NADH\text{NADH}, and ATP\text{ATP}. Folded into cristae to maximize surface area. Houses the four Electron Transport Chain (ETC) complexes, ATP Synthase, and specific transporters.

    • Matrix: Encloses pyruvate dehydrogenase, TCA cycle enzymes, fatty acid β\beta-oxidation enzymes, and urea cycle steps.

  • The Four Electron Carriers of the ETC:

    1. Flavin Mononucleotide (FMN): Tightly bound prosthetic group in Complex I. Accepts 2e−2e^- and 2H+2H^+ from NADH\text{NADH} to form FMNH2\text{FMNH}_2, then donates electrons one at a time to Fe-S clusters.

    2. Iron-Sulfur (Fe-S) Clusters: Non-heme iron-sulfur centers (2Fe-2S,4Fe-4S2\text{Fe-}2\text{S}, 4\text{Fe-}4\text{S}) present in Complexes I, II, and III. Transport 1e−1e^- at a time as iron cycles between ferric (Fe3+\text{Fe}^{3+}) and ferrous (Fe2+\text{Fe}^{2+}) states.

    3. Coenzyme Q (Ubiquinone, Q): A small, highly lipophilic, mobile electron carrier dissolved in the inner membrane Q-pool. Possesses three redox states:

    • Fully Oxidized: Ubiquinone ($ ext{Q}$).

    • Single-Electron Radical Intermediate: Semiquinone (QH∙\text{QH}^\bullet).

    • Fully Reduced: Ubiquinol (QH2\text{QH}_2, carrying 2e−2e^- and 2H+2H^+).

    1. Cytochromes: Heme-containing proteins containing a central iron atom cycling between Fe3+\text{Fe}^{3+} and Fe2+\text{Fe}^{2+} (1e−1e^- carriers).

    • Complex III contains Cytochromes bb and c1c_1.

    • Complex IV contains Cytochromes aa and a3a_3.

    • Soluble Cytochrome cc is a peripheral mobile protein located in the intermembrane space that shuttles 1e−1e^- from Complex III to Complex IV.

  • Respiratory Chain Complexes and Electron Flow:

Mitochondrial Electron Transport Chain Summary
  • Complex I (NADH:Q Oxidoreductase):

    • Accepts 2e−2e^- from matrix NADH→FMN→\text{NADH} \rightarrow \text{FMN} \rightarrow series of 8−98-9 Fe-S clusters →\rightarrow Coenzyme Q (reducing Q→QH2\text{Q} \rightarrow \text{QH}_2).

    • Uses released free energy to actively pump 4 H+4\text{ H}^+ from the matrix into the intermembrane space per NADH\text{NADH} oxidized.

  • Complex II (Succinate:Q Oxidoreductase / Succinate Dehydrogenase):

    • Integral membrane enzyme of both the TCA cycle and ETC.

    • Oxidizes Succinate →\rightarrow Fumarate, transferring 2e−→FADH2→2e^- \rightarrow \text{FADH}_2 \rightarrow Fe-S clusters →\rightarrow Coenzyme Q (reducing Q→QH2\text{Q} \rightarrow \text{QH}_2).

    • Does NOT pump protons across the inner membrane because the free energy change is insufficient.

  • Complex III (Q-Cytochrome cc Oxidoreductase):

    • Accepts 2e−2e^- from QH2\text{QH}_2 and transfers them sequentially to single-electron acceptor Cytochrome cc via the Q Cycle.

    • Q Cycle Mechanism: One QH2\text{QH}_2 donates 2e−2e^-; one electron flows to Rieske Fe-S →\rightarrow Cyt c1→c_1 \rightarrow Cyt cc. The second electron recycles through Cyt bb to reduce an oxidized Q to semiquinone. A second QH2\text{QH}_2 completes the reduction of semiquinone back to QH2\text{QH}_2.

    • Net Result per QH2\text{QH}_2 oxidized: Transfers 2e−2e^- to two Cytochrome cc molecules, removes 2 H+2\text{ H}^+ from matrix, and pumps 4 H+4\text{ H}^+ into the intermembrane space.

  • Complex IV (Cytochrome cc Oxidase):

    • Accepts 4e−4e^- from four reduced Cytochrome cc molecules.

    • Transfers electrons through CuA→Cyt a→Cyt a3-CuB\text{Cu}_A \rightarrow \text{Cyt } a \rightarrow \text{Cyt } a_3\text{-Cu}_B centers to reduce atmospheric oxygen: O2+4e−+4 H+→2 H2O\text{O}_2 + 4 e^- + 4\text{ H}^+ \rightarrow 2\text{ H}_2\text{O}.

    • Pumps 2 H+2\text{ H}^+ into the intermembrane space per 2e−2e^- pair (4 H+4\text{ H}^+ per O2\text{O}_2).

  • Total Protons Translocated:

    • Oxidation of 1 NADH1\text{ NADH} (Complex I →\rightarrow III →\rightarrow IV) pumps 10 H+10\text{ H}^+ (4+4+24 + 4 + 2).

    • Oxidation of 1 FADH21\text{ FADH}_2 (Complex II →\rightarrow III →\rightarrow IV) pumps 6 H+6\text{ H}^+ (0+4+20 + 4 + 2).

    • The Chemiosmotic Hypothesis (Peter Mitchell, 1961):

  • Free energy released by electron transport down standard reduction potential gradients is stored as an electrochemical proton gradient across the inner membrane called the Proton-Motive Force (PMF).

  • PMF=Chemical Gradient (ΔpH, matrix is alkaline)+Electrical Charge Gradient (ΔΨ,matrix is negative)\text{PMF} = \text{Chemical Gradient } (\Delta \text{pH, matrix is alkaline}) + \text{Electrical Charge Gradient } (\Delta \Psi, \text{matrix is negative}).

ATP Synthase Dynamics, Molecular Shuttles, and Bioenergetic Inhibitors

  • Structure of ATP Synthase (Complex V):

    • A rotary motor enzyme consisting of two functional domains:

    1. FoF_o Domain (Membrane-bound): Hydrophobic proton-conducting channel embedded in the inner membrane. Composed of a rotating cc-subunit ring (8−14 c8-14\,c subunits) abutting a stationary aa-subunit that contains two unjoined half-channels (one opening to intermembrane space, one to matrix).

    2. F1F_1 Domain (Catalytic): Hydrophilic complex projecting into the matrix. Composed of a catalytic headpiece (α3β3\alpha_3\beta_3 hexamer) connected to FoF_o via a central asymmetric γ\gamma-subunit stalk.

  • Proton Flow and Rotation Mechanism:

    • Protons enter the intermembrane space half-channel of subunit aa, protonating a critical glutamate residue (Glutamic acid) on a subunit of the cc-ring.

    • Neutralization of charge allows the cc-subunit to rotate into the hydrophobic membrane environment.

    • Upon completing a nearly full rotation, the cc-subunit reaches the matrix half-channel of subunit aa, where low [H+][H^+] causes glutamate to deprotonate (−COO−-\text{COO}^-), releasing H+H^+ into the matrix.

    • Rotation of the cc-ring forces rotation of the attached central γ\gamma-subunit stalk inside the stationary α3β3\alpha_3\beta_3 headpiece.

  • The Binding Change Mechanism (Paul Boyer):

    • The three catalytic β\beta-subunits of the F1F_1 headpiece cycle through three distinct conformations induced by 120∘120^\circ step-rotations of the asymmetric γ\gamma-subunit:

    1. O (Open) Conformation: Binds ADP+Pi\text{ADP} + P_i loosely; releases synthesized ATP.

    2. L (Loose) Conformation: Traps substrate ADP+Pi\text{ADP} + P_i in the catalytic pocket.

    3. T (Tight) Conformation: Compressively forces bound ADP+Pi\text{ADP} + P_i together to synthesize ATP\text{ATP} with high affinity.

    • A full 360∘360^\circ rotation of the γ\gamma-subunit drives each β\beta-subunit through O→L→T→OO \rightarrow L \rightarrow T \rightarrow O cycles, synthesizing and releasing 3 ATP3\text{ ATP} molecules.

Binding Change Mechanism of ATP Synthase
  • Cytosolic NADH Shuttle Systems:

    • The inner mitochondrial membrane is strictly impermeable to cytosolic NADH\text{NADH} generated during glycolysis.

    1. Glycerol 3-Phosphate Shuttle (Skeletal muscle, brain):

    • Cytosolic NADH\text{NADH} reduces Dihydroxyacetone phosphate (DHAP) →\rightarrow Glycerol 3-Phosphate via cytosolic G3P Dehydrogenase.

    • Glycerol 3-phosphate is re-oxidized at the outer face of the inner membrane by mitochondrial G3P Dehydrogenase, transferring 2e−2e^- to extFAD→QH2ext{FAD} \rightarrow \text{QH}_2.

    • Bypasses Complex I; yields ≈1.5 ATP\approx 1.5\text{ ATP} per cytosolic NADH\text{NADH}. Total glucose oxidation yield =30 ATP= \mathbf{30\text{ ATP}}.

    1. Malate-Aspartate Shuttle (Heart, liver):

    • Cytosolic NADH\text{NADH} reduces Oxaloacetate →\rightarrow Malate via cytosolic Malate Dehydrogenase.

    • Malate enters matrix via malate-α\alpha-ketoglutarate antiporter and is re-oxidized →\rightarrow Oxaloacetate, generating mitochondrial NADH\text{NADH}.

    • Enters Complex I; yields ≈2.5 ATP\approx 2.5\text{ ATP} per cytosolic NADH\text{NADH}. Total glucose oxidation yield =32 ATP= \mathbf{32\text{ ATP}}.

Complete Glucose Oxidation ATP Yield
  • Regulated Thermogenesis via Uncoupling:

    • Uncoupling Protein-1 (UCP-1 / Thermogenin): An integral inner membrane channel expressed in brown adipose tissue (brown fat) mitochondria.

    • Mechanism: Cold exposure releases adrenergic hormones, liberating free fatty acids that activate UCP-1. UCP-1 provides a pathway for protons to flow down the PMF back into the matrix, bypassing ATP Synthase.

    • Outcome: The energy of the proton gradient dissipates entirely as heat (nonshivering thermogenesis), vital for neonates and hibernating mammals.

Regulated Uncoupling via UCP-1 in Brown Fat
  • Inhibitors of Bioenergetics:

    1. Complex I Inhibitors: Rotenone (pesticide), Amytal (barbiturate). Block electron transfer from Fe-S clusters to CoQ.

    2. Complex III Inhibitor: Antimycin A. Blocks electron transfer from Cyt bb to Cyt c1c_1.

    3. Complex IV Inhibitors: Cyanide (CN−\text{CN}^-), Azide (N3−\text{N}_3^-) [bind ferric Fe3+\text{Fe}^{3+} form of Cyt a3a_3], Carbon Monoxide (CO\text{CO}) [binds ferrous Fe2+\text{Fe}^{2+} form of Cyt a3a_3]. Completely halt respiration.

    4. ATP Synthase Inhibitors: Oligomycin, Dicyclohexylcarbodiimide (DCC). Bind glutamate carboxylates on cc-subunits of FoF_o, blocking proton flow and stopping ATP synthesis. Secondarily halts ETC due to proton backpressure.

    5. Chemical Uncouplers: 2,42,4-Dinitrophenol (DNP), Xanthohumol. Lipophilic weak acids that bind H+H^+ in intermembrane space, diffuse across inner membrane, and release H+H^+ into matrix, destroying PMF. ETC operates maximally, O2O_2 consumption spikes, but zero ATP is synthesized (energy lost as extreme heat).

    6. ATP-ADP Translocase Inhibitors: Atractyloside (binds cytoplasmic face), Bongkrekic Acid (binds matrix face). Prevent entry of ADP\text{ADP} and exit of ATP\text{ATP}, starving ATP Synthase of substrate.